Cargando…

Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease

Background. MoCA is widely used in Parkinson's disease (PD) to assess cognition. The Test Your Memory (TYM) test is a cognitive screening tool that is self-administered. Objectives. We sought to determine (a) the optimal value of TYM to discriminate between PD patients with and without cognitiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Henderson, Emily J., Chu, Howard, Gaunt, Daisy M., Whone, Alan L., Ben-Shlomo, Yoav, Lyell, Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949348/
https://www.ncbi.nlm.nih.gov/pubmed/27478678
http://dx.doi.org/10.1155/2016/1012847
_version_ 1782443415601938432
author Henderson, Emily J.
Chu, Howard
Gaunt, Daisy M.
Whone, Alan L.
Ben-Shlomo, Yoav
Lyell, Veronica
author_facet Henderson, Emily J.
Chu, Howard
Gaunt, Daisy M.
Whone, Alan L.
Ben-Shlomo, Yoav
Lyell, Veronica
author_sort Henderson, Emily J.
collection PubMed
description Background. MoCA is widely used in Parkinson's disease (PD) to assess cognition. The Test Your Memory (TYM) test is a cognitive screening tool that is self-administered. Objectives. We sought to determine (a) the optimal value of TYM to discriminate between PD patients with and without cognitive deficits on MoCA testing, (b) equivalent MoCA and TYM scores, and (c) interrater reliability in TYM testing. Methods. We assessed the discriminant ability of TYM and the equivalence between TYM and MoCA scores and measured the interrater reliability between three raters. Results. Of the 135 subjects that completed both tests, 55% had cognitive impairment according to MoCA. A MoCA score of 25 was equivalent to a TYM score of 43-44. The area under the receiver operator characteristic (ROC) curve for TYM to differentiate between PD-normal and PD-cognitive impairment was 0.82 (95% CI 0.75 to 0.89). The optimal cutoff to distinguish PD-cognitive impairment from PD-normal was ≤45 (sensitivity 90.5%, specificity 59%) thereby correctly classifying 76.3% of patients with PD-cognitive impairment. Interrater agreement was high (0.97) and TYM was completed in under 7 minutes (interquartile range 5.33 to 8.52 minutes). Conclusions. The TYM test is a useful and less resource intensive screening test for cognitive deficits in PD.
format Online
Article
Text
id pubmed-4949348
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-49493482016-07-31 Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease Henderson, Emily J. Chu, Howard Gaunt, Daisy M. Whone, Alan L. Ben-Shlomo, Yoav Lyell, Veronica Parkinsons Dis Research Article Background. MoCA is widely used in Parkinson's disease (PD) to assess cognition. The Test Your Memory (TYM) test is a cognitive screening tool that is self-administered. Objectives. We sought to determine (a) the optimal value of TYM to discriminate between PD patients with and without cognitive deficits on MoCA testing, (b) equivalent MoCA and TYM scores, and (c) interrater reliability in TYM testing. Methods. We assessed the discriminant ability of TYM and the equivalence between TYM and MoCA scores and measured the interrater reliability between three raters. Results. Of the 135 subjects that completed both tests, 55% had cognitive impairment according to MoCA. A MoCA score of 25 was equivalent to a TYM score of 43-44. The area under the receiver operator characteristic (ROC) curve for TYM to differentiate between PD-normal and PD-cognitive impairment was 0.82 (95% CI 0.75 to 0.89). The optimal cutoff to distinguish PD-cognitive impairment from PD-normal was ≤45 (sensitivity 90.5%, specificity 59%) thereby correctly classifying 76.3% of patients with PD-cognitive impairment. Interrater agreement was high (0.97) and TYM was completed in under 7 minutes (interquartile range 5.33 to 8.52 minutes). Conclusions. The TYM test is a useful and less resource intensive screening test for cognitive deficits in PD. Hindawi Publishing Corporation 2016 2016-07-05 /pmc/articles/PMC4949348/ /pubmed/27478678 http://dx.doi.org/10.1155/2016/1012847 Text en Copyright © 2016 Emily J. Henderson et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Henderson, Emily J.
Chu, Howard
Gaunt, Daisy M.
Whone, Alan L.
Ben-Shlomo, Yoav
Lyell, Veronica
Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease
title Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease
title_full Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease
title_fullStr Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease
title_full_unstemmed Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease
title_short Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease
title_sort comparison of test your memory and montreal cognitive assessment measures in parkinson's disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949348/
https://www.ncbi.nlm.nih.gov/pubmed/27478678
http://dx.doi.org/10.1155/2016/1012847
work_keys_str_mv AT hendersonemilyj comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease
AT chuhoward comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease
AT gauntdaisym comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease
AT whonealanl comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease
AT benshlomoyoav comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease
AT lyellveronica comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease